Sweeteners Alter Gut Bacteria in Lab Tests, Combinations With Medications Show Strong Effects

A study published on June 25, 2026, in the journal Molecular Systems Biology found that approximately three-quarters of 39 common sweeteners altered the growth of at least one gut bacterial species in laboratory experiments[2][3][4]. Researchers identified a strong interaction between the sweetener isosteviol, derived from stevia, and the antidepressant duloxetine, a widely prescribed medication[1][5][6].

This research challenges the idea that sweeteners are biologically inactive, highlighting potential interactions between sweeteners, gut bacteria, and medications[3][5][6][9]. The findings emphasize the need to understand how commonly consumed substances affect the body, especially for individuals taking regular medications[3][5][6].

What the records show

A notable interaction occurred between isosteviol and duloxetine, an antidepressant known by the brand name Cymbalta[1][5][6]. When combined, these compounds significantly suppressed the growth of Roseburia intestinalis and Parabacteroides merdae[1][5][6][11]. These bacteria are important for digestive health and blood sugar regulation[3][5][6][11]. The isosteviol and duloxetine combination also reduced overall microbial diversity in a simulated gut microbiome, which is often associated with poorer gut health[5][8][11]. Further analysis indicated that this combination increased toxicity towards certain host cells and affected cells involved in inflammation and immune responses[5][7][8][11]. Funding for the research came from the European Research Council and UK Medical Research Council[2].

The timeline

What changed and for whom

What the subject has said publicly

What we could not confirm